Creating Asthma Measurements through the MORRE Study Request More Information Trial Objective Researchers want to develop new ways to measure if a patient’s asthma is improving or worsening. During the study, participants will use a FitBit® to measure steps per day and sleep quality. Participants also will answer a custom survey using their own smartphone. Researchers hope to determine the best ways to show how well asthma is controlled while being treated with omalizumab, a common asthma medication. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Participants between 18 and 85 years of age with moderate-to-severe asthma at the time of enrollment, and who are eligible for omalizumab therapy. Age: 18-85 Gender: Any Gender Estimated Time Commitment Participants will have a 2-3 in-person clinic visits of 45-90 minutes over 6-12 months. Participants will also complete monthly surveys and questionnaires at home during the 12-month period. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Stephanie Leonard 303.270.2411 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Jewish Health Principal Investigators Eileen Wang, MD, MPH + × Eileen Wang, MD, MPH Associate Professor Division of Allergy & Clinical Immunology Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Co-Investigators Flavia Hoyte, MD + × Flavia Hoyte, MD Professor Director, Allergy & Clinical Immunology Fellowship Department of Medicine Division of Allergy & Clinical Immunology View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Kanao Otsu, MD, MPH + × Kanao Otsu, MD, MPH Associate Professor Department of Medicine Division of Allergy & Clinical Immunology View Full Profile Patient Rating 4.3 out of 5 stars Make an Appoinment Laurie Manka, MD + × Laurie Manka, MD Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective Researchers want to develop new ways to measure if a patient’s asthma is improving or worsening. During the study, participants will use a FitBit® to measure steps per day and sleep quality. Participants also will answer a custom survey using their own smartphone. Researchers hope to determine the best ways to show how well asthma is controlled while being treated with omalizumab, a common asthma medication.